SCHEMBL5844995

SCHEMBL5844995

O=C(COC(O)(C(=O)c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES1 P23141 3/20 0.45
▸ L3MBTL1 Q9Y468 4/20 0.44
▸ TDP1 Q9NUW8 3/20 0.44
▸ MAPT P10636 3/20 0.42
▸ HPGD P15428 2/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SRC P12931 1/20 0.41
▸ NPC1 O15118 4/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ GSK3B P49841 2/20 0.40
▸ PTPN1 P18031 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12003255 0.81 CES1 (0.46) CES1TDP1MAPTHPGDMAPK1
SCHEMBL251616 0.81 CES1 (0.50) CES1MAPTSMN1; SMN2MEN1CYP3A4
SCHEMBL5844751 0.80 KMT2A (0.47) CES1L3MBTL1TDP1MAPK1MEN1
SCHEMBL9192066 0.79 CES1 (0.47) CES1L3MBTL1TDP1MAPTMAPK1
SCHEMBL11101775 0.78 CES1 (0.53) CES1L3MBTL1TDP1MAPTHPGD
Ether SCHEMBL6049600 0.78 CES1 (0.46) CES1MAPTSMN1; SMN2MEN1CYP3A4
SCHEMBL2814678 0.78 CES1 (0.46) CES1MAPTHPGDSRCRAB9A
SCHEMBL948686 0.78 CES1 (0.50) CES1TDP1HPGDSMN1; SMN2KDM4E
SCHEMBL621110 0.77 CES1 (0.52) CES1L3MBTL1TDP1MAPTMAPK1
SCHEMBL2819529 0.76 CES1 (0.45) CES1L3MBTL1TDP1MAPK1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6984645-B2 Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein BRISTOL-MYERS SQUIBB COMPANY (US) 2006-01-10 — — US disclosed
Send feedback